Published in BJOG on January 01, 2005
A multidimensional conceptual framework for analysing public involvement in health services research. Health Expect (2008) 2.93
Hyperacute stroke care and NHS England's business plan. BMJ (2014) 1.57
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU Int (2011) 1.51
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value Health (2011) 1.48
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant (2007) 1.47
Public health implications of establishing a national programme to screen young athletes in the UK. Br J Sports Med (2009) 1.38
The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs (2008) 1.21
Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev (2009) 1.16
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2013) 1.15
Temozolomide for high grade glioma. Cochrane Database Syst Rev (2008) 1.11
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness. Am J Rhinol (2006) 1.11
Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev (2013) 1.07
Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies. Implement Sci (2012) 1.06
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract (2006) 1.05
Extracting information from hospital records: what patients think about consent. Qual Saf Health Care (2007) 1.05
Consulting parents about the design of a randomized controlled trial of osteopathy for children with cerebral palsy. Health Expect (2011) 1.03
Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care (2012) 1.03
Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev (2011) 1.02
Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke (2012) 1.01
Why it is crucial to involve families in all stages of childhood disability research. Dev Med Child Neurol (2011) 0.99
Implementing health promotion in schools: protocol for a realist systematic review of research and experience in the United Kingdom (UK). Syst Rev (2012) 0.95
Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health (2009) 0.92
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review. BMC Health Serv Res (2013) 0.92
Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction. BMC Health Serv Res (2013) 0.92
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics (2008) 0.90
The clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review. PLoS One (2013) 0.90
Effectiveness of mealtime interventions on nutritional outcomes for the elderly living in residential care: a systematic review and meta-analysis. Ageing Res Rev (2013) 0.89
Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. Pharmacoeconomics (2005) 0.89
Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis? Stroke (2012) 0.89
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics (2013) 0.88
Chemotherapeutic wafers for High Grade Glioma. Cochrane Database Syst Rev (2008) 0.88
What value health?: A review of health state values used in early technology assessments for NICE. Appl Health Econ Health Policy (2005) 0.88
A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG (2004) 0.87
Implementing the evidence for preventing falls among community-dwelling older people: a systematic review. J Safety Res (2011) 0.87
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis. BMC Geriatr (2014) 0.87
New communities, new relations: the impact of community organization on health outcomes. Soc Sci Med (2007) 0.86
Establishing local priorities for a health research agenda. Health Expect (2012) 0.85
Patients' experience of transition onto haemodialysis: a qualitative study. J Ren Care (2009) 0.85
Barriers encountered when recruiting obese pregnant women to a dietary intervention. Nurs Times (2010) 0.84
Interventions to reduce acute paediatric hospital admissions: a systematic review. Arch Dis Child (2012) 0.84
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health (2009) 0.84
Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract (2006) 0.83
Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction? Int J Cardiol (2008) 0.83
Parents' attitudes toward the use of complementary therapy by their children with moderate or severe cerebral palsy. J Altern Complement Med (2013) 0.81
Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care (2012) 0.79
Association between methodological characteristics and outcome in health technology assessments which included case series. Int J Technol Assess Health Care (2005) 0.78
Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial. Clin Rehabil (2010) 0.78
Involving patients in drug licensing decisions. BMJ (2013) 0.77
Impact of discussion on preferences elicited in a group setting. Health Qual Life Outcomes (2006) 0.75
Predictive value of asthma medication to identify asthma sufferers. Br J Gen Pract (2002) 0.75
Prevalence of birth defects among American-Indian births in California, 1983-2010. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Adult attention deficit hyperactivity disorder (ADHD): public health implications. Perspect Public Health (2012) 0.75
Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care (2009) 0.75
NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Lancet Oncol (2011) 0.75
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis. Pharmacoeconomics (2012) 0.75
Mind sharpeners for scientists: the EQUATOR Network. Int J Technol Assess Health Care (2011) 0.75
Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis. Pharmacoeconomics (2015) 0.75
A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula. J Public Health (Oxf) (2007) 0.75
Sleep positioning systems for children with cerebral palsy. Cochrane Database Syst Rev (2015) 0.75